1Chen L, Magliano D J, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives[J]. Nat Rev Endocrinol, 2012, 8(4): 228-236.
2Ashcroft FM, Rorsman P. Diabetes mellitus and the beta cell: the last ten years[J]. Cell, 2012, 148(6): 1160-1171.
3Buchanan TA. Pancreatic beta-cell loss and preservation in type 2 diabetes[J]. Clin Ther, 2003, 25(Suppl B): B32-46.
4Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes[J]. Diabetologia, 2003, 46(1): 3-19.
5Porte D Jr, Kahn SE. Beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms[J]. Diabetes, 2001, 50(Suppl 1): S160-163.
6ADA. Standards of medical care in diabetes-2011 [J]. Diabetes Care, 2011, 34(Suppl I):S11-61.
8Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metforrnin[J]. N Engl J Med, 2002, 346(6): 393-403.
9Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance[J]. N Engl J Med, 2001, 344(18): 1343-1350.
10De Mello VD, Lindstrom J, Eriksson J, et al. Insulin secretion and its determinants in the progression of impaired glucose tolerance to type 2 diabetes in impaired glucose-tolerant individuals: the Finnish Diabetes Prevention Study[J]. Diabete Care, 2012, 35(2): 211-217.
